ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
Innovate Biopharmaceuticals Inc

Innovate Biopharmaceuticals Inc (INNT)

0.56
0.00
( 0.00% )
更新日時: 09:00:00

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

主要統計と詳細

通貨
0.56
買値
0.56
売値
0.57
出来高
-
0.00 日の範囲 0.00
0.00 52 週間の範囲 0.00
前日終値
0.56
始値
-
時刻
最終取引時間
-
平均取引量 (3 か月)
-
財務取引量
-
VWAP
-

INNT 最新ニュース

RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Dise...

RDD Pharma Enters into Non-Binding Letter of Intent to Acquire Naia Rare Diseases, Strengthening Gastroenterology Orphan Disease Pipeline Acquisition will add novel long-acting GLP-1 with plans...

Innovate Biopharmaceuticals, Inc. Announces First Patient Dosed in the First Phase 3 Clinical Trial for Patients with Celiac ...

CeD LA 3001 trial doses first patient in historic Phase 3 celiac disease trial RALEIGH, N.C., Aug. 13, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a...

Innovate Biopharmaceuticals Reports Second Quarter 2019 Results and Corporate Updates

Company is exploring potential strategic opportunities and non-dilutive sources of capital, and partnerships Continued activities of the first Phase 3 clinical trial for celiac disease including...

Innovate Biopharmaceuticals Announces Corporate Update and Expected Date for Second Quarter Earnings Release

Innovate undertakes succession planning for a chief executive officer Finance team strengthened and well positioned for future growth Second quarter earnings release expected August 8, 2019...

Innovate Biopharmaceuticals Expands Its Management team with the Addition of Ed Sitar as Its Chief Financial Officer

RALEIGH, N.C., June 24, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune...

Innovate Biopharmaceuticals Announces the Start of the First Phase 3 Clinical Trial in Celiac Disease

RALEIGH, N.C., June 10, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for autoimmune...

Innovate Biopharmaceuticals Announces Presentation of Three Posters Focusing on the Molecular Biology and Pharmacology of Lar...

Analyst Meeting to be held at 4:30pm ET today to discuss NASH data and provide clinical updates Three posters presented at DDW 2019 highlighted the protective effect and molecular mechanism of...

Innovate Biopharma Announces Analyst Event on Monday, May 20, 2019, in San Diego

RALEIGH, N.C., May 09, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (“Innovate”) (Nasdaq: INNT), a clinical stage biotechnology company focused on developing novel therapeutics for...

Innovate Biopharmaceuticals Announces Closing of $8.7 Million Registered Direct Offering

RALEIGH, N.C., May 01, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) today announced the closing of its previously announced registered direct offering of 4,318,272...

Innovate Biopharmaceuticals Announces $8.7 Million Registered Direct Offering Priced At-the-Market

RALEIGH, N.C., April 29, 2019 (GLOBE NEWSWIRE) -- Innovate Biopharmaceuticals, Inc. (NASDAQ: INNT) today announced that it has entered into securities purchase agreements with certain...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

INNT - Frequently Asked Questions (FAQ)

What is the current Innovate Biopharmaceutic... share price?
The current share price of Innovate Biopharmaceutic... is US$ 0.56
What is the 1 year trading range for Innovate Biopharmaceutic... share price?
Innovate Biopharmaceutic... has traded in the range of US$ 0.00 to US$ 0.00 during the past year

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
XTIAXTI Aerospace Inc
US$ 0.232
(163.64%)
860.53M
HOTHHoth Therapeutics Inc
US$ 1.5011
(83.15%)
57.38M
RIMEAlgorhythm Holdings Inc
US$ 0.2476
(70.99%)
211.53M
INVZWInnoviz Technologies Ltd
US$ 0.2899
(70.53%)
439.68k
MSAIMultiSensor AI Holdings Inc
US$ 3.25
(62.50%)
41.85M
SLRNACELYRIN Inc
US$ 1.94
(-44.41%)
2.57M
AMSTAmesite Inc
US$ 2.63
(-35.06%)
146.37k
LFWDLifeward Ltd
US$ 2.008
(-33.95%)
1.1M
BOXLBoxlight Corporation
US$ 1.21
(-27.98%)
2.53M
HCTIHealthcare Triangle Inc
US$ 1.3642
(-19.75%)
63.4k
XTIAXTI Aerospace Inc
US$ 0.2319
(163.52%)
862.76M
RIMEAlgorhythm Holdings Inc
US$ 0.24955
(72.34%)
212.19M
SVMHSRIVARU Holding Ltd
US$ 0.0691
(49.24%)
166.21M
CDTConduit Pharmaceuticals Inc
US$ 0.1086
(50.21%)
106.08M
CEROCERo Therapeutics Holdings Inc
US$ 0.0531
(25.53%)
83.75M